Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA:600867)
8.85
-0.16 (-1.78%)
Mar 19, 2026, 10:35 AM CST
SHA:600867 Market Cap
SHA:600867 has a market cap or net worth of 17.51 billion as of March 18, 2026. Its market cap has increased by 18.37% in one year.
Market Cap
17.51B
Enterprise Value
16.64B
Revenue
2.74B
Ranking
n/a
PE Ratio
14.37
Stock Price
8.85
Market Cap Chart
Since February 15, 2001, SHA:600867's market cap has increased from 3.86B to 17.51B, an increase of 353.47%. That is a compound annual growth rate of 6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 17.43B | 9.79% |
| Dec 31, 2025 | 15.88B | 1.06% |
| Dec 31, 2024 | 15.71B | -26.86% |
| Dec 29, 2023 | 21.48B | 17.97% |
| Dec 30, 2022 | 18.21B | -17.83% |
| Dec 31, 2021 | 22.16B | -17.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 19.64B |
| Wedge Industrial | 19.16B |
| China Resources Double-Crane Pharmaceutical | 18.83B |
| Betta Pharmaceuticals | 18.36B |
| Shandong Buchang Pharmaceuticals | 17.94B |
| Fujian Cosunter Pharmaceutical | 17.81B |
| Hybio Pharmaceutical | 16.13B |
| China Resources Jiangzhong Pharmaceutical Co.,Ltd | 16.03B |